1337 Ventures Unveils Top 10 Finalists for Alpha Startups™ INNO4HER 2026 FemTech Accelerator

1337 Ventures has announced the Top 10 finalists for the Alpha Startups™ INNO4HER 2026 programme, spotlighting a new cohort of startups developing innovative solutions to improve women’s health, well-being, and everyday lives.

Selected from a highly competitive pool of applications since the accelerator launched in January 2026, the finalists represent some of the most promising emerging ventures in the FemTech space. The founders hail from across the globe, including Malaysia, Singapore, Hong Kong, the Philippines, and Poland, reflecting the growing global demand for focused innovation in women’s health.

“The next wave of FemTech is deeper, more structural, and increasingly clinical,” said Bikesh Lakhmichand, CEO and Founding Partner of 1337 Ventures. “This year’s INNO4HER Top 10 startups are tackling some of the most complex and historically underfunded areas of women’s health, turning overlooked data, biology, and care gaps into meaningful innovation. It is encouraging to see founders pushing the boundaries of what FemTech can achieve for the future of global healthcare.”

Top 10 INNO4HER 2026 Finalists

The selected startups span a wide range of FemTech innovations, from fertility and maternal health to hormonal health management and clinical monitoring technologies.

  • Amiya (Singapore) – Building emotional support infrastructure for women’s health, starting with IVF care.

  • Bosom (Singapore) – Providing coordinated maternal healthcare across pregnancy and the postpartum period.

  • Eve Fertility (Hong Kong) – Improving affordability and accessibility of fertility care across the APAC region.

  • FemFast (Poland) – Offering AI-driven guidance to help women manage hormonal health and daily symptoms.

  • Hati Health (Philippines) – Developing holistic care solutions for women living with PCOS.

  • MenSC Labs (Singapore) – Using menstrual blood as a non-invasive and cost-effective source for stem cell research.

  • Navo Health (Singapore) – Simplifying fetal heart monitoring to support better clinical outcomes.

  • Shinaraa (Hong Kong) – Designing sustainable, technology-enabled functional womenswear.

  • Siikat (Malaysia) – Introducing plug-and-play headspa suites focused on nervous system regulation, integrated into gym environments.

  • Supple AI (Singapore) – Developing an AI-native platform designed to support women through perimenopause transitions.

The finalists are currently undergoing the final phase of a hybrid accelerator programme, receiving mentorship and structured guidance from experienced operators, investors, and corporate partners, including Epic Angels and Microsoft through its Microsoft for Startups initiative.

The programme will culminate in the INNO4HER Demo Day on 31 March 2026, hosted at Microsoft Malaysia in Kuala Lumpur, where the startups will pitch to regional venture capitalists, angel investors, and healthcare industry leaders.

The Demo Day judging panel will include:

  • Hester Spiegel-vdSteenhoven, Founding and Managing Partner at Epic Angels

  • Smita Roy, Director of Digital Native Scaling Startups (APJ) at Microsoft

  • Amelia Ong, CEO of OSK Ventures International Berhad

  • Ain Azizah Arifin, Managing Director of Bubbles O2 Sdn Bhd

Investors and ecosystem partners interested in meeting the founders or attending the Demo Day can find more information via the programme’s official website.

 

Related articles

Inside Cloud Space’s Push to Turn AI Ambition Into Business Results

Over the past year, artificial intelligence has become a...

Cortexa Labs : Setting A New Standard For AI Safety

This article is part of a series produced in...

HomeHaven Rx : Reimagining the Medicine Cabinet With Data

This article is part of a series produced in...

Navo Health and MenSC Labs Win INNO4HER 2026 As Women’s Health Innovation Gains Momentum

Singapore-based startups Navo Health and MenSC Labs have been...

LEAVE A REPLY

Please enter your comment!
Please enter your name here